We are live on ! Find out more
KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

157 hedge funds and large institutions have $1.42B invested in Chinook Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 57 increasing their positions, 49 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

460% more call options, than puts

Call options by funds: $5.61M | Put options by funds: $1M

25% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 16

16% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 49

1% more funds holding

Funds holding: 155 → 157 (+2)

5% less capital invested

Capital invested by funds: $1.49B → $1.42B (-$67.2M)

25% less funds holding in top 10

Funds holding in top 10: 8 → 6 (-2)

Holders
157
Holders Change
+2
Holders Change %
+1.29%
% of All Funds
2.5%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.1%
New
20
Increased
57
Reduced
49
Closed
16
Calls
$5.61M
Puts
$1M
Net Calls
+$4.61M
Net Calls Change
+$3.95M

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$31.3M
2
EAM
Eventide Asset Management
Massachusetts
+$25.5M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$21.1M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$11.5M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$8.68M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$25.7M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$12.8M
3
Citadel Advisors
Citadel Advisors
Florida
-$9.51M
4
EC
EcoR1 Capital
California
-$5.83M
5
Millennium Management
Millennium Management
New York
-$4.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
WTA
151
Washington Trust Advisors
Massachusetts
$1.67K +$1.72K +72 New
US Bancorp
152
US Bancorp
Minnesota
$1.57K +$1.62K +68 New
RAM
153
Riggs Asset Management
Pennsylvania
$1.5K – – –
PA
154
Parallel Advisors
California
$1.2K +$405 +17 +43%
S
155
SignatureFD
Georgia
$995 +$1.02K +43 New
SWM
156
Spire Wealth Management
Virginia
$695 +$715 +30 New
WP
157
Woodline Partners
California
– -$3.74M -142,563 Closed
ECM
158
ExodusPoint Capital Management
New York
– -$3.38M -128,955 Closed
Balyasny Asset Management
159
Balyasny Asset Management
Illinois
– -$2.36M -90,140 Closed
PVI
160
Pura Vida Investments
New York
– -$2.36M -90,000 Closed
SCM
161
Soleus Capital Management
Connecticut
– -$2.04M -78,000 Closed
EGI
162
EAM Global Investors
California
– -$1.75M -66,787 Closed
JF
163
Jump Financial
Illinois
– -$1.2M -45,868 Closed
SSA
164
Schonfeld Strategic Advisors
New York
– -$707K -26,992 Closed
Tudor Investment Corp
165
Tudor Investment Corp
Connecticut
– -$661K -25,211 Closed
GTCM
166
Gyon Technologies Capital Management
New Jersey
– -$496K -18,931 Closed
TI
167
Trexquant Investment
Connecticut
– -$355K -13,555 Closed
HF
168
HRT Financial
New York
– -$344K -13,134 Closed
PCM
169
Prelude Capital Management
New York
– -$275K -10,502 Closed
HNWAG
170
High Net Worth Advisory Group
Florida
– -$26.2K -1,000 Closed
Northwestern Mutual Wealth Management
171
Northwestern Mutual Wealth Management
Wisconsin
– -$655 -25 Closed
C
172
Covestor
United Kingdom
– +$262 +11 +183%
3 4 5 6
7

KDNY Hedge Fund Activity: Q1 2023 in Review

157 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Chinook Therapeutics, Inc. Common Stock (KDNY) for Q1 2023, worth a combined $1.42B — down 4.5% from $1.49B a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new KDNY positions and 16 closed out — a net gain of 4 holders — while 57 added to existing stakes and 49 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $31.3M. The largest seller was Baker Bros. Advisors, cutting an estimated $25.7M.

  • 157 institutional investors held Chinook Therapeutics, Inc. Common Stock (KDNY) as of Q1 2023, up from 155 in Q4 2022.
  • Funds reported $1.42B of Chinook Therapeutics, Inc. Common Stock stock for Q1 2023, down 4.5% quarter-over-quarter.
  • 20 funds opened new Chinook Therapeutics, Inc. Common Stock positions in Q1 2023 and 16 closed out, a net change of +4 holders.
  • The largest Chinook Therapeutics, Inc. Common Stock buyer in Q1 2023 was Franklin Resources, an estimated $31.3M added.
  • The largest Chinook Therapeutics, Inc. Common Stock seller in Q1 2023 was Baker Bros. Advisors, an estimated $25.7M sold.

Based on aggregated 13F filings for Q1 2023.